Brunswick expands specialist healthcare advisory offer.
Brunswick Group, a leading corporate advisory firm, announced today that Gabrielle Silver has joined as a Partner in its London office. Dr Silver is a specialist in life sciences and she will help to extend the firm’s global offer in the pharmaceutical and healthcare sector. Her appointment adds to the Group’s strength in the sector following the recent appointments of two specialists, Charis Gresser as a Partner and William Rowberry as a Director, in its London office.
“We are delighted to welcome Gabrielle to the firm as we continue to grow our Healthcare offer globally,” said Group Chief Executive Officer Susan Gilchrist. “Her extensive experience working in both the public and private side of healthcare will mean we can give our clients a completely rounded view of the market and its various stakeholders. I am delighted to welcome her to the Group.”
“Our expertise in the healthcare sector has been strengthened further by the appointment of Gabrielle,” said UK Managing Partner Simon Sporborg. “She has considerable and varied experience of the sector, and will work closely with the global team to extend and deepen our healthcare advisory offer in London and internationally.”
Gabrielle Silver joins Brunswick from GE, where she has worked since 2010 as Global Leader of Operating Room Solutions and Global Head of Neuroscience / General Medicine Strategic Marketing. Prior to that, she was Director of the CNS Franchise at Eisai Ltd, UK, and she held posts at Bristol-Myers Squibb UK and Eisai Europe Ltd. Before her career in the private sector, she worked as a Doctor in the National Health Service. She holds medical degrees from the University of Bristol and the University of London, and is on the Specialist Register with a Fellowship in Pharmaceutical Medicine (FFPM). She is also an associate Non-Executive Director for the Royal National Orthopaedic Hospital NHS Trust.
Charis Gresser comes to Brunswick from Public Health England, where she was a scientific writer. Prior to that, she was Head of Research at Meteos, providing research on value creation in the pharmaceutical sector. She worked at the Financial Times between 1997-2009, serving as a corporate reporter, a Lex columnist and the Lombard columnist. She has held positions at the United Nations, Oxfam and Pearson, and began her career working as a corporate reporter at the Daily Telegraph. She holds degrees from the London School of Hygiene and Tropical Medicine at the University of London, and from Oxford University.
Will Rowberry joined Brunswick from Circle Health, an AIM listed healthcare business, where he held the position of Head of Corporate Finance. Prior to that, Will worked at the UK Healthcare sector regulator Monitor, regulating a portfolio of hospitals, running the office of the Executive Chairman and undertaking a secondment to the Prime Ministers Delivery Unit. Will is a qualified Chartered Accountant and spent a number of years in the KPMG Transaction Services team, advising clients across a range of different financial transactions. He is also Trustee and Treasurer of a UK Charity, Action for A-T, which funds research into a rare childhood disease.
About Brunswick Group
Brunswick is an advisory firm specializing in critical issues and corporate relations. Founded in 1987, Brunswick is an organically grown, private partnership with 23 offices around the world.